Your trusted destination for CME, CPD & Medical Education across the Middle East.
International Hospital (Salmiya) / Farwaniya Hospital & KIMS, Kuwait
Dr. Reem Al Jabri is a Kuwaiti Consultant Gastroenterologist and Advanced Inflammatory Bowel Disease (IBD) Specialist based in Kuwait. She is currently associated with Farwaniya Hospital, Ministry of Health, Kuwait, and also contributes to postgraduate medical education as a Clinical Tutor and Research Supervisor for the Kuwait Board of Internal Medicine (KIMS). Her clinical and academic interests center on Crohn's disease, ulcerative colitis, therapeutic endoscopy, gastrointestinal disorders and IBD biologic therapy.
Dr. Al Jabri graduated from the Faculty of Medicine at Kuwait University in 2011. She subsequently completed postgraduate training in internal medicine in Kuwait and obtained MRCP(UK) in 2016. She then completed the Kuwait Board of Internal Medicine in 2019.
She undertook specialist training in Gastroenterology and Hepatology at the University of British Columbia (UBC) in Vancouver, Canada, completing the fellowship in 2022. She subsequently pursued further subspecialty training in advanced inflammatory bowel disease at McGill University in Montreal, completing that fellowship in 2023.
Her qualifications also include recognition from the European Society of Gastrointestinal Endoscopy (ESGE). The International Hospital Kuwait profile similarly confirms her Kuwait University medical degree, MRCP(UK), Kuwait Board qualification, UBC gastroenterology/hepatology fellowship and McGill IBD fellowship.
Dr. Al Jabri is a Consultant Gastroenterologist and Advanced IBD Specialist at Farwaniya Hospital, under Kuwait's Ministry of Health. Her specialist practice covers both general gastroenterology and complex inflammatory bowel disease.
Her hospital profile lists expertise in:
Her advanced IBD fellowship at McGill University gives her particular expertise in the management of complex Crohn's disease and ulcerative colitis.
IBD is the defining subspecialty of Dr. Al Jabri's current professional profile.
Her work encompasses the two major forms of IBD:
Crohn's disease
Ulcerative colitis
Her research specifically examines predictors of biologic failure in IBD, demonstrating an academic interest in treatment response and therapeutic optimization.
Dr. Al Jabri has an emerging research portfolio focused primarily on inflammatory bowel disease and gastrointestinal medicine.
She is the lead/corresponding author of:
“Clinical Characteristics and Predictors of Biologic Failure in Inflammatory Bowel Disease: A Retrospective, Single-Center Study from Kuwait.”
The study was published in 2025 and examined clinical characteristics associated with biologic-treatment failure among IBD patients in Kuwait. The publication identifies her as:
Consultant Gastroenterologist, Advanced Inflammatory Bowel Disease Specialist, Department of Internal Medicine, Gastroenterology, Farwaniya Hospital, Ministry of Health, Kuwait.
This work is directly aligned with her subspecialty in advanced IBD.
She also contributed to:
“Optimizing Biologic Therapy for the Prevention of Post-Operative Recurrence in Crohn’s Disease: Current Evidence and Future Perspectives.”
The work discusses strategies for reducing postoperative recurrence of Crohn's disease through appropriate biologic therapy. A 2025 preprint lists Reem Aljabri among its authors.
She was also the corresponding author of a 2025 case report:
“Cutaneous Crohn’s Disease as the First Presentation: A Natal Cleft Lesion in a Middle-Aged Woman.”
The publication identifies her as a Senior Specialist Gastroenterologist at Farwaniya Hospital and discusses an unusual extraintestinal presentation of Crohn's disease.
Dr. Al Jabri is also listed among the authors of the SEEF-IBD nationwide study, which examined the epidemiology and clinical profile of inflammatory bowel disease in Kuwait. The study was published in BMC Gastroenterology in 2026.
This is particularly relevant to her profile because it places her within a broader national research effort examining the changing burden and characteristics of IBD in Kuwait.
Dr. Al Jabri is active in postgraduate medical education.
The Kuwait Board of Internal Medicine lists her as a Clinical Tutor for the Internal Medicine Board and as a Research Supervisor. Her clinical teaching activity began at least by 2024, while her research-supervisor role is documented from 2025.
This gives her professional profile three major components:
Dr. Al Jabri is involved in regional gastroenterology activities.
She is listed as a Committee Member for the 4th KGA Congress & 1st GCC GI Forum, scheduled in Kuwait in November 2026. The meeting brings together gastroenterologists, hepatologists, endoscopists, surgeons and other GI professionals from across the Gulf.
Her committee role is particularly consistent with her regional profile as an IBD specialist and academic gastroenterologist.
For database purposes, her expertise can be divided into:
Gastroenterology & Hepatology
Inflammatory Bowel Disease

Kuwait Gastroenterology Association (KGA)
Kuwait Gastroenterology Association (KGA)